-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
-
Summary
-
NEXIEN BIOPHARMA, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Basic history and change rate from Q1 2021 to Q1 2025.
- NEXIEN BIOPHARMA, INC. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Mar 2025 was 70,772,196, a 6.6% increase year-over-year.
- NEXIEN BIOPHARMA, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 66,193,840, a 6.2% increase from 2023.
- NEXIEN BIOPHARMA, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 62,333,322, a 7.7% increase from 2022.
- NEXIEN BIOPHARMA, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 57,860,108, a 4.4% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)